Biblio
Export 1653 results:
Author Title Type [ Year] Filters: First Letter Of Last Name is C [Clear All Filters]
“Two-Year Changes in Physical Activity and Concurrent Changes in Cognitive Function in a Cohort of Adults with Metabolic Syndrome.”, J Alzheimers Dis, vol. 95, no. 3, pp. 887-899, 2023.
, “Two-Year Changes in Physical Activity and Concurrent Changes in Cognitive Function in a Cohort of Adults with Metabolic Syndrome.”, J Alzheimers Dis, vol. 95, no. 3, pp. 887-899, 2023.
, “Two-Year Changes in Physical Activity and Concurrent Changes in Cognitive Function in a Cohort of Adults with Metabolic Syndrome.”, J Alzheimers Dis, vol. 95, no. 3, pp. 887-899, 2023.
, “Validation of a Multivariate Prediction Model of the Clinical Progression of Alzheimer's Disease in a Community-Dwelling Multiethnic Cohort.”, J Alzheimers Dis, vol. 95, no. 1, pp. 93-117, 2023.
, “African Ancestry Individuals with Higher Educational Attainment Are Resilient to Alzheimer's Disease Measured by pTau181.”, J Alzheimers Dis, vol. 98, no. 1, pp. 221-229, 2024.
, “Altered Neuronal Activity Patterns of the Prefrontal Cortex in Alzheimer's Disease After Transcranial Alternating Current Stimulation: A Resting-State fMRI Study.”, J Alzheimers Dis, 2024.
, “The Association Between Neuropathological Lesions and Body Mass Index Is Independent of Cognitive Abilities.”, J Alzheimers Dis, 2024.
, “Cognitive Outcomes in Autosomal-Dominant Alzheimer's Disease: A Comprehensive Review from a Colombian Kindred with the Presenilin-1 E280A Mutation.”, J Alzheimers Dis, 2024.
, “Epistatic Features and Machine Learning Improve Alzheimer's Disease Risk Prediction Over Polygenic Risk Scores.”, J Alzheimers Dis, vol. 99, no. 4, pp. 1425-1440, 2024.
, “Epistatic Features and Machine Learning Improve Alzheimer's Disease Risk Prediction Over Polygenic Risk Scores.”, J Alzheimers Dis, vol. 99, no. 4, pp. 1425-1440, 2024.
, “FACEmemory®, an Innovative Online Platform for Episodic Memory Pre-Screening: Findings from the First 3,000 Participants.”, J Alzheimers Dis, vol. 97, no. 3, pp. 1173-1187, 2024.
, “First Biodistribution Study of [68Ga]Ga-NOTA-Insulin Following Intranasal Administration in Adult Vervet Monkeys.”, J Alzheimers Dis, vol. 101, no. 1, pp. 309-320, 2024.
, “First Biodistribution Study of [68Ga]Ga-NOTA-Insulin Following Intranasal Administration in Adult Vervet Monkeys.”, J Alzheimers Dis, vol. 101, no. 1, pp. 309-320, 2024.
, “Hypertension, Cognitive Decline, and Mild Cognitive Impairment Among Diverse Hispanics/Latinos: Study of Latinos-Investigation of Neurocognitive Aging Results (SOL-INCA).”, J Alzheimers Dis, vol. 97, no. 3, pp. 1449-1461, 2024.
, “Impaired Skeletal Development by Disruption of Presenilin-1 in Pigs and Generation of Novel Pig Models for Alzheimer's Disease.”, J Alzheimers Dis, 2024.
, “Improving Healthcare Quality and Clinical Outcomes for Persons with Dementia in the Sub-Acute Hospital Through Person-Centered Care Practice.”, J Alzheimers Dis, vol. 98, no. 2, pp. 619-628, 2024.
, “Improving Healthcare Quality and Clinical Outcomes for Persons with Dementia in the Sub-Acute Hospital Through Person-Centered Care Practice.”, J Alzheimers Dis, vol. 98, no. 2, pp. 619-628, 2024.
, “Improving Healthcare Quality and Clinical Outcomes for Persons with Dementia in the Sub-Acute Hospital Through Person-Centered Care Practice.”, J Alzheimers Dis, vol. 98, no. 2, pp. 619-628, 2024.
, “Investigating the efficacy of ergothioneine to delay cognitive decline in mild cognitively impaired subjects: A pilot study.”, J Alzheimers Dis, p. 13872877241291253, 2024.
, “Investigating the efficacy of ergothioneine to delay cognitive decline in mild cognitively impaired subjects: A pilot study.”, J Alzheimers Dis, p. 13872877241291253, 2024.
, “Investigating the efficacy of ergothioneine to delay cognitive decline in mild cognitively impaired subjects: A pilot study.”, J Alzheimers Dis, p. 13872877241291253, 2024.
, “Long Non-Coding RNA Profile in Genetic Symptomatic and Presymptomatic Frontotemporal Dementia: A GENFI Study.”, J Alzheimers Dis, 2024.
, “Markers of amyloid-β deposition and burden of enlarged perivascular spaces in patients with cognitive impairment and small vessel disease.”, J Alzheimers Dis, p. 13872877241296012, 2024.
, “Mayo Normative Studies: Amyloid and Neurodegeneration Negative Normative Data for the Auditory Verbal Learning Test and Sex-Specific Sensitivity to Mild Cognitive Impairment/Dementia.”, J Alzheimers Dis, vol. 100, no. 3, pp. 879-897, 2024.
, ,